A PROSPECTIVE STUDY OF IN-OFFICE DIAGNOSTIC VITREOUS SAMPLING IN PATIENTS WITH VITREORETINAL PATHOLOGY

Abstract

This prospective study has shown that in-office vitreous sampling of 50 microL to 100 microL is a safe and reproducible procedure. Larger randomized studies will be helpful to further assess the safety and long-term effects of in-office diagnostic vitreous sampling.